Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 75

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 9B
Chunk 75
---
: Number of Shares of Stocks  
    All Other
    Option Awards: Number of Securities Underlying   
    Exercise or
    Base Price of Option  
    Closing stock
    price on Award  
    Grant Date
    Fair Value of Stock and Option  

    Grant  
    Threshold  
    Target  
    Maximum  
    Threshold  
    Target  
    Maximum  
    or
    Units  
    Options  
    Awards  
    date  
    Awards 
  
    Name 
    Date(1)  
    ($)  
    ($)  
    ($)  
    (#)  
    (#)  
    (#)  
    (#)  
    (#)  
    ($/Sh)  
    ($/Sh)  

    Erez Aminov, CEO 
     8/27/2024  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     1,960,170(2) 
    $5.02(4) 
    $5.26  
    $7,513,332 
  
    Michelle Yanez, CFO 
     8/27/2024  
     -  
        
     -  
     -  
     -  
     -  
     -  
     200,000(3) 
    $5.02(4) 
    $5.26  
    $782,000 
  
    Christopher Chapman, former
    CEO 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     - 
  
    Nathen Fuentes, former CFO 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     - 

(1)
The “Grant Date” represents the date on which the Compensation Committee of the Board took action to grant the applicable
award

(2)
The